🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Delirium After Living Donor Renal Transplantation

    approved small molecule active

    1 trial

  2. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Renal Function

    approved small molecule active

    1 trial

  3. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Overall Survival

    approved small molecule completed

    1 trial

  4. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Older Patients

    approved small molecule active

    1 trial

  5. Dexmedetomidine Injectable Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule completed

    1 trial

  6. Dexmedetomidine-esketamine combination

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule active

    1 trial

  7. Diane-35 pretreatment

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    approved small molecule active

    1 trial

  8. Dimethyl fumarate

    Biogen

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  9. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  10. Double dose of PPI

    Takeda

    Dyspepsia

    approved small molecule completed

    1 trial

  11. Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning

    The George Institute

    Breast cancer female NOS

    approved small molecule active

    1 trial

  12. Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial

  13. Dupilumab

    Regeneron UK Limited

    Allergic Contact Dermatitis

    approved small molecule active

    1 trial

  14. Dupilumab Injectable Product

    Regeneron UK Limited

    Asthma

    approved small molecule active

    1 trial

  15. Dupilumab Prefilled Syringe

    Regeneron UK Limited

    Nasal Polyps

    approved small molecule active

    1 trial

  16. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  17. Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases

    approved small molecule active

    1 trial

  18. EFFIMIA 0,250 mg/0,035mg, Compresse

    Italfarmaco S.p.A.

    Female contraception.

    approved small molecule active

    1 trial

  19. ELEVIDYS

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial

  20. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  21. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial

  22. ESTECLIN 300 MG CAPSULE RIGIDE

    Zafatek

    COPD

    approved small molecule active

    1 trial

  23. ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE

    The George Institute

    Cervical cancer

    approved small molecule active

    1 trial

  24. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources